Axiogenesis Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 32

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Axiogenesis General Information

Description

Operator of a biotechnology company intended to focus on in vitro models of healthy and diseased cell types and tissues. The company specializes in stem cell-derived, in vitro differentiated cardiomyocytes, neurons and other cell types, as well as drug development assays and disease models for fields of drug discovery and development and life sciences research.

Contact Information

Website
www.axiogenesis.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Nattermannallee 1
  • Building S20
  • 50829 Cologne
  • Germany
Primary Industry
Biotechnology
Acquirer
Ncardia
Vertical(s)
Life Sciences
Corporate Office
  • Nattermannallee 1
  • Building S20
  • 50829 Cologne
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Axiogenesis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 18-Sep-2017 Completed Startup
6. Later Stage VC 03-May-2016 Completed Startup
5. Later Stage VC 05-Jun-2012 Completed Startup
4. PIPE 23-Mar-2011 Completed Startup
3. IPO 19-Dec-2007 Completed Startup
2. Later Stage VC Completed Startup
1. University Spin-Out 01-Nov-2000 Completed Startup
To view Axiogenesis’s complete valuation and funding history, request access »

Axiogenesis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to focus on in vitro models of healthy and diseased cell types and tissues.
Biotechnology
Cologne, Germany
32 As of 2016

Cambridge, United Kingdom
 

Centennial, CO
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Axiogenesis Competitors (69)

One of Axiogenesis’s 69 competitors is bit.bio, a Venture Capital-Backed company based in Cambridge, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
bit.bio Venture Capital-Backed Cambridge, United Kingdom
Novus Biologicals Formerly PE-Backed Centennial, CO
Moraga Biotechnology Corporation Corporation Los Angeles, CA
Aviva Systems Biology Formerly VC-backed San Diego, CA
Genetix Biotherapeutics Private Equity-Backed Somerville, MA
You’re viewing 5 of 69 competitors. Get the full list »

Axiogenesis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Axiogenesis Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Donghai Securities Holding Company Minority
High-Tech Gründerfonds Venture Capital Minority
Venture Plus Venture Capital Minority
To view Axiogenesis’s complete investors history, request access »

Ready to get started?

Request a free trial

Axiogenesis FAQs

  • When was Axiogenesis founded?

    Axiogenesis was founded in 2000.

  • Where is Axiogenesis headquartered?

    Axiogenesis is headquartered in Cologne, Germany.

  • What is the size of Axiogenesis?

    Axiogenesis has 32 total employees.

  • What industry is Axiogenesis in?

    Axiogenesis’s primary industry is Biotechnology.

  • Is Axiogenesis a private or public company?

    Axiogenesis is a Private company.

  • What is Axiogenesis’s current revenue?

    The current revenue for Axiogenesis is .

  • Who are Axiogenesis’s investors?

    Donghai Securities, High-Tech Gründerfonds, and Venture Plus have invested in Axiogenesis.

  • Who are Axiogenesis’s competitors?

    bit.bio, Novus Biologicals, Moraga Biotechnology Corporation, Aviva Systems Biology, and Genetix Biotherapeutics are some of the 69 competitors of Axiogenesis.

  • When was Axiogenesis acquired?

    Axiogenesis was acquired on 18-Sep-2017.

  • Who acquired Axiogenesis?

    Axiogenesis was acquired by Ncardia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process